Table 2 Distribution of serum NETs in 95 CRC patients with various clinicopathological parameters
Parameter | Serum specimen (n = 95) | ||
|---|---|---|---|
(n,%) | NETs (MPO-DNA) | P value | |
Gender | |||
 Male (n,%) | 52 (54.7%) | 0.33 (0.19) | 0.39 |
 Female (n,%) | 43 (45.3%) | 0.27 (0.10) |  |
Age | |||
  < 60 (n,%) | 38 (40%) | 0.33 (0.14) | 0.41 |
  ≥ 60 (n,%) | 57 (60%) | 0.29 (0.09) |  |
Location | |||
 Colon (n,%) | 47 (49.5%) | 0.32 (0.11) | 0.27 |
 Rectum (n,%) | 48 (50.5%) | 0.29 (0.12) |  |
Differentiation | |||
 Poorly (n,%) | 31 (32.6%) | 0.34 (0.10) | 0.001 |
 Well + Moderately (n,%) | 64 (67.4%) | 0.26 (0.06) |  |
TNM stage | |||
 I + II (n,%) | 45 (47.4%) | 0.25 (0.08) | 0.001 |
 III + IV (n,%) | 50 (52.6%) | 0.37 (0.12) |  |
Metastasis | |||
 Present (n,%) | 50 (52.6%) | 0.39 (0.12) | 0.001 |
 Absent (n,%) | 45 (47.4%) | 0.26 (0.14) |  |